Interestingly, saxagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, which increases plasma GLP-1 concentration, appears to selectively inhibit ASC, suggesting a role in preventing the spread of AD pathology (173). This evidence concerns the gene DPP4 and Alzheimer disease.